Related Experiment Video
Updated: May 25, 2026
Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
Animal models for microbicide studies
Ronald S Veazey1, Robin J Shattock, Per Johan Klasse
1Division of Comparative Pathology, Tulane National Primate Research Center, Tulane University School of Medicine, Covington, LA 70433, USA. rveazey@tulane.edu
Abstract:
There have been encouraging recent successes in the development of safe and effective topical microbicides to prevent vaginal or rectal HIV-1 transmission, based on the use of anti-retroviral drugs. However, much work remains to be accomplished before a microbicide becomes a standard element of prevention science strategies. Animal models should continue to play an important role in pre-clinical testing, with emphasis on safety, pharmacokinetic and efficacy testing.
Insights
Topical microbicides using anti-retroviral drugs show promise for preventing HIV-1 transmission. Further pre-clinical research in animal models is crucial for safety, pharmacokinetic, and efficacy testing before widespread use.
Area of Science:
- Infectious disease prevention
- Pharmacology
- Virology
Background:
- Recent advancements in topical microbicide development for HIV-1 prevention.
- Anti-retroviral drugs form the basis for current safe and effective microbicide candidates.
- Challenges remain in integrating microbicides into comprehensive HIV-1 prevention strategies.
Purpose of the Study:
- To highlight the progress and ongoing needs in topical microbicide research.
- To emphasize the critical role of pre-clinical testing in microbicide development.
- To advocate for continued research using animal models.
Main Methods:
- Review of recent successes in topical microbicide development.
- Discussion of the role of anti-retroviral drugs in microbicides.
- Emphasis on pre-clinical testing methodologies.
Main Results:
- Encouraging successes have been achieved in developing safe and effective topical microbicides.
- Anti-retroviral drug-based microbicides show potential for preventing HIV-1 transmission.
- Significant work is still required for microbicide implementation.
Conclusions:
- Topical microbicides represent a promising avenue for HIV-1 prevention.
- Continued research, particularly in animal models, is essential for safety, pharmacokinetic, and efficacy evaluation.
- Animal models are vital for advancing microbicide development towards standard prevention strategies.
